HX044

· Hanx Biopharmaceuticals (Wuhan) Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for HX044, covering 2025-01-14 to 2025-01-14. Get the full timeline:

Most recent: Clinical Trial Update: HX044,FIH Study in Patients with Advanced Solid Tumor Malignancies [Phase 1, Phase 2]